Related Experiment Videos
Mucolipidosis III is genetically heterogeneous
Abstract:
Mucolipidosis III (ML III), or pseudo-Hurler polydystrophy, is an inherited childhood disorder characterized biochemically by low activities and abnormal electrophoretic patterns of multiple lysosomal enzymes in fibroblasts. The primary deficiency of ML III has been proposed to be in UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase. However, variation in this enzyme and in other biochemical properties of different ML III lines has been observed. Therefore, we investigated genetic heterogeneity within the disorder by complementation analysis. Heterokaryon cell fractions were generated by fusing together ML III fibroblast lines. When pairs of cells complemented, correction of lysosomal enzyme activities and electrophoretic patterns was observed. Twelve fibroblast lines from 10 sibships were analyzed and three distinct complementation groups were characterized. One complementation group represents the classical ML III disorder. A single cell line identifies a second complementation group. The cell lines comprising a third complementation group have a number of biochemical characteristics different from classical ML III and may represent a genetically distinct disorder.
Insights
Genetic heterogeneity in Mucolipidosis III (ML III) was investigated using cell fusion. Three distinct complementation groups were identified, suggesting potential genetic variations within this childhood disorder.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Mucolipidosis III (ML III), also known as pseudo-Hurler polydystrophy, is an inherited childhood disorder.
- It is characterized by low activities and abnormal electrophoretic patterns of multiple lysosomal enzymes in fibroblasts.
- The primary defect is thought to involve UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase, but variations exist.
Purpose of the Study:
- To investigate genetic heterogeneity within Mucolipidosis III.
- To determine if different ML III cell lines represent distinct genetic disorders.
Main Methods:
- Complementation analysis was performed using fibroblast cell lines from ML III patients.
- Heterokaryon cell fusions were generated by fusing ML III fibroblast lines.
- Correction of lysosomal enzyme activities and electrophoretic patterns was assessed after cell fusion.
Main Results:
- Twelve fibroblast lines from 10 sibships were analyzed.
- Three distinct complementation groups were identified.
- One group represented classical ML III, a second was defined by a single cell line, and a third exhibited biochemical differences, suggesting a distinct disorder.
Conclusions:
- Mucolipidosis III exhibits genetic heterogeneity.
- The identified complementation groups indicate at least three distinct genetic entities within ML III.
- A third complementation group may represent a genetically distinct disorder separate from classical ML III.